Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Prospective, Open, Multicenter Clinical Trial of Eltrombopag Combined With Diacerein in Eltrombopag-inefficient or Relapsed ITP [Phase 2]
Phase 2 open multicenter trial evaluating eltrombopag combined with diacerein in eltrombopag-inefficient or relapsed thrombocytopenia (ITP) …
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Thrombosomes® in Bleeding Thrombocytopenic Patients [Phase 1]
Phase 1 clinical trial update for Thrombosomes in thrombocytopenic patients completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy [Phase 2, Phase 3]
Clinical trial updates for eltrombopag olamine in thrombocytopenia associated with chronic myeloid leukemia or myelofibrosis during tyrosine…
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating umbilical cord–derived mesenchymal stem cells for treatment-induced myelosuppression in hematologic mali…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure [Phase 4]
Phase 4 clinical trial evaluating avatrombopag for thrombocytopenia in patients with chronic liver disease undergoing an elective procedure.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment [Phase 4]
Phase 4 clinical trial investigating the efficacy and safety of avatrombopag for thrombocytopenia in patients with HBV-related acute-on-chro…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Herombopag Olamine in the Treatment of Thrombocytopenia After Chemotherapy [Phase 4]
Phase 4 clinical trial update for Herombopag Olamine in treating thrombocytopenia after chemotherapy, sponsored by Huazhong University of Sc…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Effect of Herbal Formulation on Thrombocytes Count [Phase 3]
Phase 3 clinical trial evaluating a herbal formulation for thrombocytopenia, status unknown.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) [Phase 2]
Phase 2 trial evaluating epsilon-aminocaproic acid to prevent bleeding in patients with hematological malignancies and thrombocytopenia; stu…
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP [Phase 2]
A Phase 2 multicenter randomized open-label trial comparing chidamide plus high-dose dexamethasone (HD-DEX) to HD-DEX alone in thrombocytope…
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE [Phase 3]
A Phase 3 trial evaluating cyclophosphamide and hydroxychloroquine for thrombocytopenia in systemic lupus erythematosus was terminated.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients [Phase 4]
Phase 4 trial evaluating recombinant human thrombopoietin for increasing platelet levels in ICU patients with pneumonia and thrombocytopenia…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes [Phase 2]
Phase 2 trial update evaluating eltrombopag for thrombocytopenia in patients with low- to intermediate-risk myelodysplastic syndromes (MDS).
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: XIENCE 28 USA Study [NA]
Clinical trial update for XIENCE 28 USA study has completed with results posted in December 2021.
-
FDA approval · 2021-10-14FDA Approved: DOPTELET — Supplemental Application (AkaRx, Inc.)
FDA approved a supplemental application for DOPTELET (avatrombopag maleate) from AkaRx, Inc., likely to modify the label or add/expand an in…
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia [Phase 1, Phase 2]
Clinical trial in pediatric patients investigating tranexamic acid for thrombocytopenia has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia [Phase 4]
A Phase 4 clinical trial evaluating thromboprophylaxis for venous thromboembolism in acutely ill medical inpatients with thrombocytopenia wa…
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. [Phase 2]
Phase 2 trial assessing eltrombopag for delayed post-transplant thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia [Phase 4]
Phase 4 trial investigating avatrombopag for thrombocytopenia in patients with liver failure and related conditions, status currently unknow…
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of avatrombopag in cancer patients with thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets [Phase 1]
Phase 1 safety study of dimethyl sulfoxide cryopreserved platelets has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Avatrombopaq In Patients With Cirrhosis [Phase 4]
Phase 4 trial update for avatrombopag in patients with cirrhosis and thrombocytopenia, focusing on safety and efficacy in reducing procedura…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: American Trial Using Tranexamic Acid in Thrombocytopenia [Phase 3]
Phase 3 clinical trial update on tranexamic acid for thrombocytopenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma [Phase 2]
Phase 2 clinical trial evaluating avatrombopag for primary prevention of cytarabine-induced thrombocytopenia in lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: XIENCE 28 Global Study [NA]
Clinical trial update for the XIENCE 28 Global Study is completed with posted results.